{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:15Z","timestamp":1787032815314,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.100006","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:14:12Z","timestamp":1766585652000},"source":"Crossref","is-referenced-by-count":1,"title":["Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation: Current Evidence and Its Potential Role as First-Line Therapy"],"prefix":"10.7759","author":[{"given":"Saleh","family":"Aloraini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Alqarawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101757","article-title":"Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF Registry","volume":"55","author":"Romiti GF","year":"2023","unstructured":"Romiti GF, Proietti M, Bonini N, Ding WY, Boriani G, Huisman MV, Lip GY. Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF Registry. EClinicalMedicine. 2023, 55:101757. 10.1016\/j.eclinm.2022.101757","journal-title":"EClinicalMedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04154","article-title":"Global, regional, and national burdens of atrial fibrillation\/flutter from 1990 to 2019: an age-period-cohort analysis using the Global Burden of Disease 2019 study","volume":"13","author":"Li X","year":"2023","unstructured":"Li X, Liu Z, Jiang X, et al.. Global, regional, and national burdens of atrial fibrillation\/flutter from 1990 to 2019: an age-period-cohort analysis using the Global Burden of Disease 2019 study. J Glob Health. 2023, 13:04154. 10.7189\/jogh.13.04154","journal-title":"J Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2022.130108","article-title":"Atrial fibrillation: the year of 2021 in review","volume":"13","author":"Sardana M","year":"2022","unstructured":"Sardana M, Doshi RN. Atrial fibrillation: the year of 2021 in review. J Innov Card Rhythm Manag. 2022, 13:4847-51. 10.19102\/icrm.2022.130108","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2024.10.003","article-title":"Trends in health care expenditures and incremental health care cost in adults with atrial fibrillation in the United States","volume":"6","author":"Serpa F","year":"2025","unstructured":"Serpa F, Tale A, Zimetbaum PJ, Kramer DB. Trends in health care expenditures and incremental health care cost in adults with atrial fibrillation in the United States. Heart Rhythm O2. 2025, 6:11-20. 10.1016\/j.hroo.2024.10.003","journal-title":"Heart Rhythm O2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.11.1321","article-title":"Health care resource utilization and costs associated with atrial fibrillation and rural-urban disparities","volume":"28","author":"Jiang S","year":"2022","unstructured":"Jiang S, Seslar SP, Sloan LA, Hansen RN. Health care resource utilization and costs associated with atrial fibrillation and rural-urban disparities. J Manag Care Spec Pharm. 2022, 28:1321-30. 10.18553\/jmcp.2022.28.11.1321","journal-title":"J Manag Care Spec Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder IC","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al.. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024, 45:3314-414. 10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.12.015","article-title":"The cost of atrial fibrillation: a systematic review","volume":"27","author":"Buja A","year":"2024","unstructured":"Buja A, Rebba V, Montecchio L, et al.. The cost of atrial fibrillation: a systematic review. Value Health. 2024, 27:527-41. 10.1016\/j.jval.2023.12.015","journal-title":"Value Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2007.08.001","article-title":"Atrial fibrillation: a historical perspective","volume":"92","author":"Khasnis A","year":"2008","unstructured":"Khasnis A, Thakur RK. Atrial fibrillation: a historical perspective. Med Clin North Am. 2008, 92:1-15, ix. 10.1016\/j.mcna.2007.08.001","journal-title":"Med Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02501.x","article-title":"One hundred years of atrial fibrillation","volume":"60","author":"Aronson JK","year":"2005","unstructured":"Aronson JK. One hundred years of atrial fibrillation. Br J Clin Pharmacol. 2005, 60:345-6. 10.1111\/j.1365-2125.2005.02501.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse DG","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, et al.. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347:1825-33. 10.1056\/NEJMoa021328","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder IC","year":"2010","unstructured":"Van Gelder IC, Groenveld HF, Crijns HJ, et al.. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010, 362:1363-73. 10.1056\/NEJMoa1001337","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof P","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al.. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020, 383:1305-16. 10.1056\/NEJMoa2019422","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni OM","year":"2021","unstructured":"Wazni OM, Dandamudi G, Sood N, et al.. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021, 384:316-24. 10.1056\/NEJMoa2029554","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck KH","year":"2021","unstructured":"Kuck KH, Lebedev DS, Mikhaylov EN, et al.. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021, 23:362-9. 10.1093\/europace\/euaa298","journal-title":"Europace"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae304","article-title":"Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation","volume":"27","author":"Schuijt E","year":"2024","unstructured":"Schuijt E, Scherr D, Plank G, Schotten U, Heijman J. Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. Europace. 2024, 27:304. 10.1093\/europace\/euae304","journal-title":"Europace"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1962.03050440040012","article-title":"New method for terminating cardiac arrhythmias","volume":"182","author":"Lown B","year":"1962","unstructured":"Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias. JAMA. 1962, 182:548. 10.1001\/jama.1962.03050440040012","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.008192","article-title":"Pulmonary vein isolation with single pulse irreversible electroporation: a first in human study in 10 patients with atrial fibrillation","volume":"13","author":"Loh P","year":"2020","unstructured":"Loh P, van Es R, Groen MH, Neven K, Kassenberg W, Wittkampf FH, Doevendans PA. Pulmonary vein isolation with single pulse irreversible electroporation: a first in human study in 10 patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2020, 13:e008192. 10.1161\/CIRCEP.119.008192","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.02.058","article-title":"The first ablation","volume":"21","author":"Scheinman MM","year":"2024","unstructured":"Scheinman MM. The first ablation. Heart Rhythm. 2024, 21:519-20. 10.1016\/j.hrthm.2024.02.058","journal-title":"Heart Rhythm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Ha\u00efssaguerre M","year":"1998","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, et al.. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998, 339:659-66. 10.1056\/NEJM199809033391003","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler PM","year":"2023","unstructured":"Kistler PM, Chieng D, Sugumar H, et al.. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA. 2023, 329:127-35. 10.1001\/jama.2022.23722","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02449.x","article-title":"Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat","volume":"60","author":"Kumana CR","year":"2005","unstructured":"Kumana CR, Cheung BM, Cheung GT, Ovedal T, Pederson B, Lauder IJ. Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol. 2005, 60:347-54. 10.1111\/j.1365-2125.2005.02449.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2018.10.006","article-title":"Secular trends in success rate of catheter ablation for atrial fibrillation: the SMASH-AF cohort","volume":"208","author":"Perino AC","year":"2019","unstructured":"Perino AC, Leef GC, Cluckey A, et al.. Secular trends in success rate of catheter ablation for atrial fibrillation: the SMASH-AF cohort. Am Heart J. 2019, 208:110-9. 10.1016\/j.ahj.2018.10.006","journal-title":"Am Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche NF","year":"2014","unstructured":"Marrouche NF, Wilber D, Hindricks G, et al.. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014, 311:498-506. 10.1001\/jama.2014.3","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-025-02086-9","article-title":"Head-to-head comparison of pulsed-field ablation, high-power short-duration ablation, cryoballoon and conventional radiofrequency ablation by MRI-based ablation lesion assessment","author":"Regany-Closa M","year":"2025","unstructured":"Regany-Closa M, Pomes-Perez J, Invers-Rubio E, et al.. Head-to-head comparison of pulsed-field ablation, high-power short-duration ablation, cryoballoon and conventional radiofrequency ablation by MRI-based ablation lesion assessment. J Interv Card Electrophysiol. 2025, 10.1007\/s10840-025-02086-9","journal-title":"J Interv Card Electrophysiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jce.16366","article-title":"VARIPULSE: A step-by-step guide to pulmonary vein isolation","volume":"35","author":"Nair DG","year":"2024","unstructured":"Nair DG, Gomez T, De Potter T. VARIPULSE: A step-by-step guide to pulmonary vein isolation. J Cardiovasc Electrophysiol. 2024, 35:1817-27. 10.1111\/jce.16366","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss M","year":"2021","unstructured":"Kuniss M, Pavlovic N, Velagic V, et al.. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021, 23:1033-41. 10.1093\/europace\/euab029","journal-title":"Europace"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-03983-z","article-title":"Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis","volume":"24","author":"Chander S","year":"2024","unstructured":"Chander S, Kumari R, Luhana S, et al.. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024, 24:321. 10.1186\/s12872-024-03983-z","journal-title":"BMC Cardiovasc Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"6","author":"Turagam MK","year":"2021","unstructured":"Turagam MK, Musikantow D, Whang W, et al.. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials. JAMA Cardiol. 2021, 6:697-705. 10.1001\/jamacardio.2021.0852","journal-title":"JAMA Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade JG","year":"2023","unstructured":"Andrade JG, Deyell MW, Macle L, et al.. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023, 388:105-16. 10.1056\/NEJMoa2212540","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309781","article-title":"Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial","volume":"103","author":"Nielsen JC","year":"2017","unstructured":"Nielsen JC, Johannessen A, Raatikainen P, et al.. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017, 103:368-76. 10.1136\/heartjnl-2016-309781","journal-title":"Heart"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.07.061","article-title":"Catheter ablation vs antiarrhythmic drug therapy for first-line treatment of atrial fibrillation in United States clinical practice","author":"Pimentel RC","year":"2025","unstructured":"Pimentel RC, Khanna R, Maccioni S, Zhang D, Piccini JP. Catheter ablation vs antiarrhythmic drug therapy for first-line treatment of atrial fibrillation in United States clinical practice. Heart Rhythm. 2025, 10.1016\/j.hrthm.2025.07.061","journal-title":"Heart Rhythm"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-022-01388-6","article-title":"Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry","volume":"66","author":"Zucchelli G","year":"2023","unstructured":"Zucchelli G, Chun KR, Khelae SK, et al.. Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry. J Interv Card Electrophysiol. 2023, 66:711-22. 10.1007\/s10840-022-01388-6","journal-title":"J Interv Card Electrophysiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf179","article-title":"Pulsed-field ablation vs. thermal ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Badertscher P","year":"2025","unstructured":"Badertscher P, Du Fay de Lavallaz J, Reichlin T, et al.. Pulsed-field ablation vs. thermal ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace. 2025, 27:euaf179. 10.1093\/europace\/euaf179","journal-title":"Europace"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.05.001","article-title":"Pulsed field vs conventional thermal\u00a0ablation for paroxysmal atrial\u00a0fibrillation: recurrent\u00a0atrial arrhythmia burden","volume":"84","author":"Reddy VY","year":"2024","unstructured":"Reddy VY, Mansour M, Calkins H, et al.. Pulsed field vs conventional thermal\u00a0ablation for paroxysmal atrial\u00a0fibrillation: recurrent\u00a0atrial arrhythmia burden. J Am Coll Cardiol. 2024, 84:61-74. 10.1016\/j.jacc.2024.05.001","journal-title":"J Am Coll Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf193","article-title":"Another day in FARADISE? Lessons learned from a real-world global registry of pulsed field ablation with the pentaspline catheter for atrial fibrillation ablation","volume":"27","author":"Schiavone M","year":"2025","unstructured":"Schiavone M, Di Biase L. Another day in FARADISE? Lessons learned from a real-world global registry of pulsed field ablation with the pentaspline catheter for atrial fibrillation ablation. Europace. 2025, 27:10.1093\/europace\/euaf193","journal-title":"Europace"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502280","article-title":"Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation","volume":"392","author":"Reichlin T","year":"2025","unstructured":"Reichlin T, Kueffer T, Badertscher P, et al.. Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation. N Engl J Med. 2025, 392:1497-507. 10.1056\/NEJMoa2502280","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/pace.14971","article-title":"Meta-analysis of pulsed-field ablation versus cryoablation for atrial fibrillation","volume":"47","author":"Zhang H","year":"2024","unstructured":"Zhang H, Zhang H, Lu H, Mao Y, Chen J. Meta-analysis of pulsed-field ablation versus cryoablation for atrial fibrillation. Pacing Clin Electrophysiol. 2024, 47:603-13. 10.1111\/pace.14971","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/postmj\/qgaf049","article-title":"Pulsed-field ablation versus radiofrequency or cryoballoon thermal ablation in atrial fibrillation: a systematic review and meta-analysis","volume":"101","author":"Kaddoura R","year":"2025","unstructured":"Kaddoura R, Abushanab D, Asaad N. Pulsed-field ablation versus radiofrequency or cryoballoon thermal ablation in atrial fibrillation: a systematic review and meta-analysis. Postgrad Med J. 2025, 101:690-703. 10.1093\/postmj\/qgaf049","journal-title":"Postgrad Med J"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2369433","article-title":"A cost-consequence analysis comparing three cardiac ablation strategies for the treatment of paroxysmal atrial fibrillation","volume":"27","author":"van de Kar M","year":"2024","unstructured":"van de Kar M, Dekker L, Timmermanns I, et al.. A cost-consequence analysis comparing three cardiac ablation strategies for the treatment of paroxysmal atrial fibrillation. J Med Econ. 2024, 27:826-35. 10.1080\/13696998.2024.2369433","journal-title":"J Med Econ"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma A","year":"2023","unstructured":"Verma A, Haines DE, Boersma LV, et al.. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023, 147:1422-32. 10.1161\/CIRCULATIONAHA.123.063988","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011780","article-title":"Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspire study","volume":"16","author":"Duytschaever M","year":"2023","unstructured":"Duytschaever M, De Potter T, Grimaldi M, et al.. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspire study. Circ Arrhythm Electrophysiol. 2023, 16:e011780. 10.1161\/CIRCEP.122.011780","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.070333","article-title":"Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial","volume":"150","author":"Reddy VY","year":"2024","unstructured":"Reddy VY, Calkins H, Mansour M, et al.. Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial. Circulation. 2024, 150:1174-86. 10.1161\/CIRCULATIONAHA.124.070333","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae053","article-title":"Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study","volume":"26","author":"Metzner A","year":"2024","unstructured":"Metzner A, Fiala M, Vijgen J, et al.. Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study. Europace. 2024, 26:10.1093\/europace\/euae053","journal-title":"Europace"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.03.930","article-title":"Po-03-108 pulsed field ablation as a first-line therapy for paroxysmal atrial fibrillation - sub-study of the EU-PORIA registry","volume":"21","author":"Neven K","year":"2024","unstructured":"Neven K, Schmidt B, Bordignon S, et al.. Po-03-108 pulsed field ablation as a first-line therapy for paroxysmal atrial fibrillation - sub-study of the EU-PORIA registry. Heart Rhythm. 2024, 21:327. 10.1016\/j.hrthm.2024.03.930","journal-title":"Heart Rhythm"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.124.013088","article-title":"Pulsed field ablation as first-line therapy for atrial fibrillation: a substudy of the EU-PORIA registry","volume":"17","author":"F\u00fcting A","year":"2024","unstructured":"F\u00fcting A, Neven K, Bordignon S, et al.. Pulsed field ablation as first-line therapy for atrial fibrillation: a substudy of the EU-PORIA registry. Circ Arrhythm Electrophysiol. 2024, 17:e013088. 10.1161\/CIRCEP.124.013088","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.009692","article-title":"Ablation versus antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation: a meta-analysis of randomized trials","volume":"14","author":"Kheiri B","year":"2021","unstructured":"Kheiri B, Simpson TF, Przybylowicz R, et al.. Ablation versus antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation: a meta-analysis of randomized trials. Circ Arrhythm Electrophysiol. 2021, 14:e009692. 10.1161\/CIRCEP.120.009692","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.04.042","article-title":"Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial","volume":"86","author":"Osmancik P","year":"2025","unstructured":"Osmancik P, Roubicek T, Havranek S, et al.. Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial. J Am Coll Cardiol. 2025, 86:18-28. 10.1016\/j.jacc.2025.04.042","journal-title":"J Am Coll Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2023.03.021","article-title":"Pulsed-field ablation on mitral isthmus in persistent atrial fibrillation: preliminary data on efficacy and safety","volume":"9","author":"Davong B","year":"2023","unstructured":"Davong B, Adeli\u00f1o R, Delasnerie H, et al.. Pulsed-field ablation on mitral isthmus in persistent atrial fibrillation: preliminary data on efficacy and safety. JACC Clin Electrophysiol. 2023, 9:1070-81. 10.1016\/j.jacep.2023.03.021","journal-title":"JACC Clin Electrophysiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae038","article-title":"Pulmonary vein narrowing after pulsed field versus thermal ablation","volume":"26","author":"Mansour M","year":"2024","unstructured":"Mansour M, Gerstenfeld EP, Patel C, et al.. Pulmonary vein narrowing after pulsed field versus thermal ablation. Europace. 2024, 26:10.1093\/europace\/euae038","journal-title":"Europace"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2025.04.005","article-title":"Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: acute results from the FRANCE-PFA registry","volume":"6","author":"Chaumont C","year":"2025","unstructured":"Chaumont C, Laredo M, Thomas O, et al.. Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: acute results from the FRANCE-PFA registry. Heart Rhythm O2. 2025, 6:911-9. 10.1016\/j.hroo.2025.04.005","journal-title":"Heart Rhythm O2"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf182","article-title":"Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry","volume":"27","author":"Boersma LV","year":"2025","unstructured":"Boersma LV, Sz\u00e9plaki G, Dello Russo A, et al.. Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry. Europace. 2025, 27:10.1093\/europace\/euaf182","journal-title":"Europace"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020719","article-title":"Efficacy and safety of pulsed field ablation in atrial fibrillation: a systematic review","volume":"12","author":"Shtembari J","year":"2023","unstructured":"Shtembari J, Shrestha DB, Pathak BD, et al.. Efficacy and safety of pulsed field ablation in atrial fibrillation: a systematic review. J Clin Med. 2023, 12:719. 10.3390\/jcm12020719","journal-title":"J Clin Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euac050","article-title":"Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)","volume":"24","author":"Ekanem E","year":"2022","unstructured":"Ekanem E, Reddy VY, Schmidt B, et al.. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace. 2022, 24:1256-66. 10.1093\/europace\/euac050","journal-title":"Europace"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-023-01651-4","article-title":"Pulsed-field vs. cryoballoon vs. radiofrequency ablation: a propensity score matched comparison of one-year outcomes after pulmonary vein isolation in patients with paroxysmal atrial fibrillation","volume":"67","author":"Maurhofer J","year":"2024","unstructured":"Maurhofer J, Kueffer T, Madaffari A, et al.. Pulsed-field vs. cryoballoon vs. radiofrequency ablation: a propensity score matched comparison of one-year outcomes after pulmonary vein isolation in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2024, 67:389-97. 10.1007\/s10840-023-01651-4","journal-title":"J Interv Card Electrophysiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.123.011920","article-title":"Pulsed field versus cryoballoon pulmonary vein isolation for atrial fibrillation: efficacy, safety, and long-term follow-up in a 400-patient cohort","volume":"16","author":"Urbanek L","year":"2023","unstructured":"Urbanek L, Bordignon S, Schaack D, et al.. Pulsed field versus cryoballoon pulmonary vein isolation for atrial fibrillation: efficacy, safety, and long-term follow-up in a 400-patient cohort. Circ Arrhythm Electrophysiol. 2023, 16:389-98. 10.1161\/CIRCEP.123.011920","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.09.044","article-title":"Long-term health-related quality of life and rhythm outcomes of catheter ablation versus antiarrhythmic drugs in patients with atrial fibrillation","volume":"22","author":"Svedung Wettervik V","year":"2025","unstructured":"Svedung Wettervik V, Schwieler J, Bergfeldt L, et al.. Long-term health-related quality of life and rhythm outcomes of catheter ablation versus antiarrhythmic drugs in patients with atrial fibrillation. Heart Rhythm. 2025, 22:944-51. 10.1016\/j.hrthm.2024.09.044","journal-title":"Heart Rhythm"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2024.15014","article-title":"Selected advances in the anti-arrhythmic management of atrial fibrillation: 2023","volume":"15","author":"Reiffel JA","year":"2024","unstructured":"Reiffel JA. Selected advances in the anti-arrhythmic management of atrial fibrillation: 2023. J Innov Card Rhythm Manag. 2024, 15:5728-34. 10.19102\/icrm.2024.15014","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade JG","year":"2021","unstructured":"Andrade JG, Wells GA, Deyell MW, et al.. Cryoablation or drug therapy for initial treatment of atrial fibrillation. N Engl J Med. 2021, 384:305-15. 10.1056\/NEJMoa2029980","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-024-01912-w","article-title":"Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial","volume":"68","author":"Yamane T","year":"2025","unstructured":"Yamane T, Sasano T, Tomita H, et al.. Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial. J Interv Card Electrophysiol. 2025, 68:149-57. 10.1007\/s10840-024-01912-w","journal-title":"J Interv Card Electrophysiol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2024.01.005","article-title":"Prospective 1-year results of atrial fibrillation ablation using the pentaspline pulsed field ablation catheter: the initial French experience","volume":"117","author":"Chaumont C","year":"2024","unstructured":"Chaumont C, McDonnell E, Boveda S, et al.. Prospective 1-year results of atrial fibrillation ablation using the pentaspline pulsed field ablation catheter: the initial French experience. Arch Cardiovasc Dis. 2024, 117:249-54. 10.1016\/j.acvd.2024.01.005","journal-title":"Arch Cardiovasc Dis"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027871","article-title":"Effects of ablation versus drug therapy on quality of life by sex in atrial fibrillation: results from the CABANA trial","volume":"12","author":"Zeitler EP","year":"2023","unstructured":"Zeitler EP, Li Y, Silverstein AP, et al.. Effects of ablation versus drug therapy on quality of life by sex in atrial fibrillation: results from the CABANA trial. J Am Heart Assoc. 2023, 12:e027871. 10.1161\/JAHA.122.027871","journal-title":"J Am Heart Assoc"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer DL","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, et al.. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019, 321:1261-74. 10.1001\/jama.2019.0693","journal-title":"JAMA"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist C","year":"2019","unstructured":"Blomstr\u00f6m-Lundqvist C, Gizurarson S, Schwieler J, et al.. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. JAMA. 2019, 321:1059-68. 10.1001\/jama.2019.0335","journal-title":"JAMA"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.10.019","article-title":"Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY trial","volume":"9","author":"Osorio J","year":"2023","unstructured":"Osorio J, Hussein AA, Delaughter MC, et al.. Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY trial. JACC Clin Electrophysiol. 2023, 9:468-80. 10.1016\/j.jacep.2022.10.019","journal-title":"JACC Clin Electrophysiol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf174","article-title":"Dual energy for pulmonary vein isolation using focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 12-month results","volume":"27","author":"De Potter T","year":"2025","unstructured":"De Potter T, Scherr D, P\u00fcrerfellner H, et al.. Dual energy for pulmonary vein isolation using focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 12-month results. Europace. 2025, 27:10.1093\/europace\/euaf174","journal-title":"Europace"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-16166-3","article-title":"Meta-analysis of comprehensive prognostic evaluation in patients with atrial fibrillation complicated by heart failure after catheter ablation","volume":"15","author":"Zhang X","year":"2025","unstructured":"Zhang X, Wei M, Xue P, Tang B. Meta-analysis of comprehensive prognostic evaluation in patients with atrial fibrillation complicated by heart failure after catheter ablation. Sci Rep. 2025, 15:32785. 10.1038\/s41598-025-16166-3","journal-title":"Sci Rep"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20230684","article-title":"Randomized study comparing radiofrequency ablation with the PVAC Gold system vs. Antiarrhythmic drugs in elderly patients with symptomatic atrial fibrillation","volume":"121","author":"Martins LC","year":"2024","unstructured":"Martins LC, Pisani CF, Dorfman FK, et al.. Randomized study comparing radiofrequency ablation with the PVAC Gold system vs. Antiarrhythmic drugs in elderly patients with symptomatic atrial fibrillation. Arq Bras Cardiol. 2024, 121:e20230684. 10.36660\/abc.20230684","journal-title":"Arq Bras Cardiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv385","article-title":"Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial","volume":"18","author":"De Greef Y","year":"2016","unstructured":"De Greef Y, Dekker L, Boersma L, et al.. Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial. Europace. 2016, 18:687-95. 10.1093\/europace\/euv385","journal-title":"Europace"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae291","article-title":"Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilization","volume":"45","author":"Crowley R","year":"2024","unstructured":"Crowley R, Chieng D, Sugumar H, et al.. Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilization. Eur Heart J. 2024, 45:2604-16. 10.1093\/eurheartj\/ehae291","journal-title":"Eur Heart J"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2441071","article-title":"Comparing pulsed field ablation and thermal energy catheter ablation for paroxysmal atrial fibrillation: a cost-effectiveness analysis of the ADVENT trial","volume":"28","author":"Padula WV","year":"2025","unstructured":"Padula WV, Paffrath A, Jacobsen CM, et al.. Comparing pulsed field ablation and thermal energy catheter ablation for paroxysmal atrial fibrillation: a cost-effectiveness analysis of the ADVENT trial. J Med Econ. 2025, 28:127-35. 10.1080\/13696998.2024.2441071","journal-title":"J Med Econ"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-079881","article-title":"Pulsed field ablation with the pentaspline catheter compared with cryoablation for the treatment of paroxysmal atrial fibrillation in the UK NHS: a cost-comparison analysis","volume":"14","author":"Duxbury C","year":"2024","unstructured":"Duxbury C, Begley D, Heck PM. Pulsed field ablation with the pentaspline catheter compared with cryoablation for the treatment of paroxysmal atrial fibrillation in the UK NHS: a cost-comparison analysis. BMJ Open. 2024, 14:e079881. 10.1136\/bmjopen-2023-079881","journal-title":"BMJ Open"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.03.017","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"21","author":"Tzeis S","year":"2024","unstructured":"Tzeis S, Gerstenfeld EP, Kalman J, et al.. 2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2024, 21:e31-e149. 10.1016\/j.hrthm.2024.03.017","journal-title":"Heart Rhythm"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019, 140:e125-51. 10.1161\/CIR.0000000000000665","journal-title":"Circulation"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448438-pulsed-field-ablation-for-paroxysmal-atrial-fibrillation-current-evidence-and-its-potential-role-as-first-line-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:14:13Z","timestamp":1766585653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448438-pulsed-field-ablation-for-paroxysmal-atrial-fibrillation-current-evidence-and-its-potential-role-as-first-line-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":75,"URL":"https:\/\/doi.org\/10.7759\/cureus.100006","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}